SI-BONE (NASDAQ:SIBN) Posts Earnings Results

SI-BONE (NASDAQ:SIBN) announced its quarterly earnings results on Monday. The company reported ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05, Zacks reports. SI-BONE had a negative return on equity of 22.51% and a negative net margin of 23.82%. SI-BONE updated its FY 2025 guidance to EPS.

SI-BONE Price Performance

NASDAQ SIBN opened at $17.47 on Tuesday. SI-BONE has a twelve month low of $11.70 and a twelve month high of $20.60. The company has a debt-to-equity ratio of 0.22, a quick ratio of 7.22 and a current ratio of 8.25. The stock has a market capitalization of $732.66 million, a PE ratio of -18.99 and a beta of 1.17. The stock has a 50-day simple moving average of $15.73 and a 200 day simple moving average of $14.69.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on SIBN shares. Truist Financial boosted their price target on SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Needham & Company LLC reaffirmed a “buy” rating and issued a $19.00 price target on shares of SI-BONE in a research report on Monday, January 13th. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $23.00.

Insider Buying and Selling

In related news, insider Anthony J. Recupero sold 3,670 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $13.90, for a total transaction of $51,013.00. Following the completion of the transaction, the insider now owns 222,814 shares of the company’s stock, valued at approximately $3,097,114.60. The trade was a 1.62 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Anshul Maheshwari sold 5,304 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $13.91, for a total value of $73,778.64. Following the transaction, the chief financial officer now owns 189,319 shares in the company, valued at $2,633,427.29. This represents a 2.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 9,311 shares of company stock valued at $130,356. Insiders own 3.90% of the company’s stock.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.